All
  • All
  • ELISA Kit
  • Protein
  • Antibody
  • Molecular Biology Product
  • Small Molecule
All
  • All
  • ELISA Kit
  • Protein
  • Antibody
  • Molecular Biology Product
  • Small Molecule

Mouse Complement C2(C2) ELISA kit

Protocol
Code CSB-EL003658MO
Size 96T,5×96T,10×96T
Price Request a Quote or Start an on-line Chat
Trial Size 24T ELISA Kit Trial Size (Only USD$150/ kit)
* The sample kit cost can be deducted from your subsequent orders of 96T full size kits of the same analyte at 1/5 per kit, until depleted in 6 months. Apply now

Product Details

Target Name
complement component 2
Alternative Names
C2Complement C2 ELISA Kit; EC 3.4.21.43 ELISA Kit; C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment] ELISA Kit
Abbreviation
C2
Uniprot No.
P21180
Species
Mus musculus (Mouse)
Sample Types
serum, plasma, tissue homogenates
Detection Range
18.75 ng/mL-300 ng/mL
Sensitivity
18.75 ng/mL
Assay Time
1-5h
Sample Volume
50-100ul
Detection Wavelength
450 nm
Research Area
Immunology
Assay Principle
quantitative
Measurement
Competitive
ELISA Data Analysis
ELISA Standard Curve & Curve Expert software
Troubleshooting
and FAQs
ELISA kit FAQs
Storage
Store at 2-8°C. Please refer to protocol.
Lead Time
3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx
Description

This Mouse Complement C2 (C2) ELISA Kit was designed for the quantitative measurement of Mouse Complement C2 (C2) protein in serum, plasma, tissue homogenates. It is a Competitive ELISA kit, its detection range is 18.75 ng/mL-300 ng/mL and the sensitivity is 18.75 ng/mL.

Related Products

C2 Proteins

See all products about C2 >>

Customer Reviews and Q&A

■ Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
(From Uniprot)
Component C2 which is part of the classical pathway of the complement system is cleaved by activated factor C1 into two fragments: C2b and C2a. C2a, a serine protease, then combines with complement factor C4b to generate the C3 or C5 convertase.
Gene References into Functions
  1. Data indicate that activation of C5 in experimental cerebral malaria likely occurs via coagulation enzymes of the extrinsic protease pathway. PMID: 22689574
  2. The more pronounced lack of complement activation in Bf/C2-/- mice leads to uncontrolled infection due to an opsonophagocytic defect PMID: 18672286
Subcellular Location
Secreted.
Protein Families
Peptidase S1 family
Database Links
Promotions
Obtain Rewards by Referring A Friend
Reward For Reviews
Transmembrane Protein Questionnaire with Gifts
Free antibody trial
Contact Us

  Email: [email protected]
  Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

Related Articles
Does Antibody-dependent Enhancement Occur in SARS-CoV-2 Infection? Streptococcus pneumoniae, a Primary Cause of Pneumonia The True Face of Tumor Suppressor Gene p53 The Overview of One Category of Important Cell Receptors: Receptor Tyrosine Kinases TNFR1: A Multifaceted Molecule in Cancer, Another Promising Therapeutic Target for COVID-19 2021 Insights on the CAR-T Cell Therapy: the Most Popular Targets for Solid Tumor! CD24: A Key Element in the EXO-CD24 Technique for Combating COVID-19 NKG2D, a Powerful Molecule Involved In CAR-T And Car-NK Cell Therapy DNA Damage and Repair Chemokine Receptor CCR4: the Key Role of CCR4+Treg Cells in Cancer Immunotherapy DT3C, a Powerful Tool for ADC Drug Internalization In Vitro Proteolysis Targeting Chimera (PROTAC): A CLDN9: Another Key Regulator for Tumors or Hearing Loss from the CLDN Family! DDR1: a Novel Member of the RTKs Family, a Potential Target for Tumor Therapy! CD93, A Rising Star in Anti-Tumor Therapy CD31- A Complex Function Molecule Surface Markers That Help You Identify Lymphocytes ERBB3/HER3: a New Target for Tumor Therapy, a Driver Gene of Multi-Tumors Cell Differentiation Determines the Fate of Cells CD19-The Most Popular Target with CAR T-Cell Therapy TFR1 (TFRC): a Stimulator of Fe Transport Affects Anemia, Neurodegenerative Disorders and Cancers! Tuberculosis--A Resurgent ULBP1: a Potent Member of NKG2D Ligands in CAR-T Therapy for Multiple Hematological and Solid Tumors! Homeobox Transcription Factor- NANOG DSG2: a Vital Member of Desmosomal Cadherin Family, an Exciting New Target for Cardiomyopathy, Adenovirus, and Tumors! MYL9: a New Member of Myosin Motors, a Key Driver of Cancer Cell Dynamic Regulation? New Mechanism, NRP1 Enhances the Ability of SARS-CoV-2 Infection Stem Cell-What a Miraculous Resource in Human Body CEACAM5: A Promising Member of CEACAM Family, A Potential Target for ADC Drug Research! CD147, a New Target of SARS-CoV-2 Invasion A Comprehensive Exploration into Amyotrophic Lateral Sclerosis CD46, A Complement Regulator CD20 Monoclonal Antibodies Drugs: There is an Explosion of New mAbs Against CD20! VSIG4: a Prominent B7 Family Costimulatory Molecule or Complement Receptor in Cancers and Inflammatory Diseases! Protein Kinases Overview: Definition, Types, Function, Activation Mechanism, etc. Exploring Neurodegeneration: A Comprehensive Guide for Researchers CD22- What A Powerful Co-receptor of B Cell Receptor GIPR: the Crucial Regulator of Glucose and Lipid Metabolism in Diabetes and Obesity! How Does Histone Modification Affect Gene Expression? CD48: An Emerging Human Immune Co-stimulatory Molecule, Friend or Foe? CD146, A Powerful Tumor Marker Introduction of Hepatocellular Carcinoma Related Signaling Pathways ACE2, The Hottest Target of SARS-CoV-2 Invasion Tetraspanin CD81: a Key Receptor for Hepatitis C Virus (HCV), an Established Exosome Marker, a Promising Target for Antiviral or Antitumor Research! OMA1-A Potential Cancer Therapy Target GLP-1R: An Energy Metabolism Regulator of GPCR Family, an Effective Drug Target for Type 2 Diabetes Therapy! TASIN represents a promising approach for prevention of colorectal cancer Latest Changes in Journal Impact Factor Mucin-17/MUC17: An Unexpected Target for Tumor Immune Therapy, Notably Gastric Cancer! How to express a protein with bioactivity? Myosin Regulatory Light Chains (MYL12A and MYL12B): the New Functional Ligands for CD69, Potential Targets for Cardiac Disease or Tumors Research? Do You Really Know Neurons and Glia Cells in Nerve System? The Memory thief - Alzheimer's disease A Group of Promising Proteins - Cell Cycle Markers The Overview of Interleukin The Overview of Autophagy PI3K-Akt Signaling Pathway and Cancer CEACAM6: a Potent CEA Family Molecule, a New Tumor Marker or Anti-Cancer Target! IL2RA (CD25): A Specific Marker of Tregs Functions as Both Immune Modulators and Targeted Agents in Various Diseases! GUCY2C: a Novel Target in Tumor Immunotherapy, Specially in Colorectal Cancer CAR T Therapy! SEMA4D/CD100: As an Important Immunoregulator to Improve Immunotherapy CADM1: an Immunoglobulin Superfamily Molecule, a New Tumor Suppressor Gene! Dipeptidase 3 (DPEP3): an Emerging Member of the DPEP Family, a Potential Therapeutic Target in Male Fertility or Tumor Research! ELISA Data Analysis How to Do The Pre-experiment before Your ELISA Experiment Four Types of ELISA 11 tips for choosing your right ELISA kit Do you Often Trouble in These Problems of ELISA? Problems and Solutions in ELISA Experiments
Related pathways
Complement and coagulation cascades
CUSABIO guaranteed quality
icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of email
Email
[email protected]
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Privacy Policy